CRH
CRH NYSE Construction Materials Financials FY2016βFY2025
CRH's revenue rose 5.3% to $37.4 billion in fiscal 2025. Its operating margin was 14.5%, up from 13.8% a year earlier. Free cash flow was $2.9 billion, up 20.8%. It paid out $1.2 billion in dividends and buybacks, 41% of free cash flow. The diluted share count fell 1.8%.
What CRH does
No business description yet.
- Legal name
- CRH public limited company
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-009043
0000849395
Revenue and margins
CRH had $37.4B of revenue in fiscal 2025, up 5.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.9B in fiscal 2025, 7.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CRH returned $1.2B to shareholders in fiscal 2025, 41% of free cash flow. The diluted share count fell 1.8%.
Value CRH yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$14.1B and divides by 677.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 15.0x Β· peers 17.7x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably CRH can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.8B | $5.9B | $6.3B | $3.7B | $4.1B |
| Debt incl. finance leases | $10.5B | $9.7B | $11.8B | $14.2B | $18.2B |
| Net debt / EBITDA | 1.0x | 0.7x | 0.9x | 1.6x | 1.9x |
| Debt / equity | 0.5x | 0.4x | 0.6x | 0.7x | 0.8x |
| Interest coverage | 10.6x | 11.1x | 11.1x | 8.1x | 6.7x |
| Current ratio | 1.9x | 1.8x | 1.7x | 1.4x | 1.7x |
| Quick ratio | 1.4x | 1.3x | 1.3x | 0.9x | 1.1x |
| Total assets | $44.7B | $45.3B | $47.5B | $50.6B | $58.3B |
| Total liabilities | $23.8B | $22.3B | $25.8B | $27.8B | $32.9B |
| Shareholders' equity | $20.2B | $22.2B | $20.9B | $21.6B | $24.0B |
| Net debt (β = net cash) | $4.7B | $3.8B | $5.4B | $10.5B | $14.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
2 insiders
Sold, 12 months
$0.2M
1 insider
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β4.0% | β3.1% | β3.4% |
| Altman Z'' | 3.98 | 3.54 | 3.59 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| CRH CRH | $56.8B | 5.3% | 14.5% | 7.8% | 11.8% | 15.0x | 7 | |
| Vulcan Materials VMC | $34.3B | 7.1% | 20.4% | 14.3% | 9.8% | 31.2x | 8 | Compare β |
| Martin Marietta Materials MLM | $30.5B | 8.6% | 23.4% | 15.9% | 7.7% | 12.5x | 7 | Compare β |
| Knife River KNF | $3.0B | 8.5% | 9.1% | β2.2% | 9.1% | 21.7x | 3 | Compare β |
| Eagle Materials EXP | $5.4B | 2.1% | β | 8.6% | 16.3% | 13.8x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | β | $27.4B | $28.1B | $25.9B | $29.2B | $32.7B | $34.9B | $35.6B | $37.4B |
| Gross profit | β | β | $9.1B | $9.3B | $8.6B | $9.8B | $10.8B | $12.0B | $12.7B | $13.5B |
| Operating income | β | β | $2.4B | $2.8B | $2.0B | $3.3B | $3.8B | $4.2B | $4.9B | $5.4B |
| Interest expense | β | β | $399M | $387M | $438M | $315M | $344M | $376M | $612M | $810M |
| Pretax income | β | β | $2.0B | $2.2B | $1.5B | $3.1B | $3.5B | $4.0B | $4.7B | $4.8B |
| Income tax | β | β | $467M | $534M | $445M | $650M | $762M | $925M | $1.1B | $1.0B |
| Net income | β | β | $2.9B | $1.7B | $1.1B | $2.6B | $3.9B | $3.2B | $3.5B | $3.8B |
| Diluted EPS | β | β | $344.70 | $2.13 | $1.42 | $3.32 | $5.11 | $4.33 | $5.02 | $5.51 |
| Diluted shares | 0.83B | 0.84B | 0.84B | 0.81B | 0.79B | 0.79B | 0.76B | 0.73B | 0.69B | 0.68B |
| Cash flow | ||||||||||
| Cash from operations | β | β | $2.2B | $3.9B | $3.9B | $4.0B | $3.8B | $5.0B | $5.0B | $5.6B |
| Capital expenditure | β | β | $1.3B | $1.4B | $996M | $1.6B | $1.5B | $1.8B | $2.6B | $2.7B |
| Free cash flow | β | β | $922M | $2.5B | $2.9B | $2.4B | $2.3B | $3.2B | $2.4B | $2.9B |
| Depreciation and amortization | β | β | β | β | $1.6B | $1.6B | $1.6B | $1.6B | $1.8B | $2.2B |
| Stock-based compensation | β | β | $79.0M | $86.0M | $96.0M | $110M | $101M | $123M | $125M | $143M |
| Acquisitions | $0.0M | $0.0M | $4.1B | $727M | $351M | $1.5B | $3.3B | $640M | $4.9B | $3.9B |
| Share buybacks | $0.0M | $0.0M | $921M | $954M | $249M | $896M | $1.2B | $3.1B | $1.5B | $1.2B |
| Dividends paid | $0.0M | $0.0M | $619M | $652M | $707M | $906M | $917M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $1.5B | $1.6B | $956M | $1.8B | $2.1B | $3.1B | $1.5B | $1.2B |
| Balance sheet | ||||||||||
| Cash and short-term investments | β | β | $2.7B | $4.2B | $7.7B | $5.8B | $5.9B | $6.3B | $3.7B | $4.1B |
| Total debt | β | β | $17.2B | $15.8B | $12.2B | $10.5B | $9.6B | $11.6B | $14.0B | $17.7B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $81.0M | $117M | $257M | $534M |
| Current assets | β | β | $17.4B | $17.3B | $15.0B | $14.0B | $14.8B | $16.9B | $14.1B | $15.3B |
| Current liabilities | β | β | $13.5B | $12.9B | $7.5B | $7.6B | $8.0B | $10.0B | $10.3B | $8.8B |
| Inventory | $0.0M | $0.0M | $3.5B | $3.1B | $3.1B | $3.6B | $4.2B | $4.3B | $4.8B | $5.3B |
| Property and equipment, net | β | β | $18.0B | $19.6B | $19.3B | $19.5B | $17.8B | $17.8B | $21.5B | $24.9B |
| Total assets | β | β | $46.8B | $47.6B | $44.9B | $44.7B | $45.3B | $47.5B | $50.6B | $58.3B |
| Total liabilities | β | β | $27.8B | $28.0B | $24.6B | $23.8B | $22.3B | $25.8B | $27.8B | $32.9B |
| Shareholders' equity | β | $18.0B | $18.4B | $19.0B | $19.7B | $20.2B | $22.2B | $20.9B | $21.6B | $24.0B |
| Margins | ||||||||||
| Gross margin | β | β | 33.0% | 33.0% | 33.1% | 33.7% | 33.1% | 34.2% | 35.7% | 36.1% |
| Operating margin | β | β | 8.9% | 9.9% | 7.8% | 11.4% | 11.6% | 12.0% | 13.9% | 14.5% |
| EBITDA margin | β | β | β | β | 13.8% | 16.7% | 16.5% | 16.7% | 18.9% | 20.3% |
| Net margin | β | β | 10.5% | 6.1% | 4.3% | 9.0% | 11.8% | 9.1% | 9.8% | 10.0% |
| FCF margin | β | β | 3.4% | 8.9% | 11.4% | 8.3% | 7.0% | 9.2% | 6.8% | 7.8% |
| Returns | ||||||||||
| Return on capital | β | β | β | 6.5% | 5.0% | 10.3% | 11.3% | 12.1% | 12.7% | 11.8% |
| Return on capital employed | β | β | β | 8.2% | 5.6% | 8.9% | 10.2% | 11.2% | 12.7% | 12.1% |
| Return on equity | β | β | β | 9.2% | 5.8% | 13.2% | 18.2% | 14.8% | 16.5% | 16.5% |
| Return on assets | β | β | β | 3.6% | 2.4% | 5.9% | 8.6% | 6.9% | 7.1% | 6.9% |
| Growth | ||||||||||
| Revenue growth | β | β | β | 2.5% | β8.0% | 12.8% | 12.0% | 6.8% | 1.8% | 5.3% |
| Net income growth | β | β | β | β40.5% | β34.7% | 134.4% | 46.8% | β17.7% | 9.9% | 7.5% |
| EPS growth | β | β | β | β99.4% | β33.2% | 133.8% | 53.9% | β15.3% | 15.9% | 9.8% |
| FCF growth | β | β | β | 171.9% | 17.4% | β17.6% | β6.1% | 40.5% | β24.7% | 20.8% |
| Share count change | 2.2% | 0.8% | β0.5% | β3.5% | β2.1% | β0.5% | β2.9% | β4.6% | β5.4% | β1.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | 1.3x | 1.0x | 0.7x | 0.9x | 1.6x | 1.9x |
| Debt / equity | β | β | 0.9x | 0.8x | 0.6x | 0.5x | 0.4x | 0.6x | 0.7x | 0.8x |
| Interest coverage | β | β | 6.1x | 7.2x | 4.6x | 10.6x | 11.1x | 11.1x | 8.1x | 6.7x |
| Current ratio | β | β | 1.3x | 1.3x | 2.0x | 1.9x | 1.8x | 1.7x | 1.4x | 1.7x |
| Quick ratio | β | β | 1.0x | 1.1x | 1.6x | 1.4x | 1.3x | 1.3x | 0.9x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | β | β | 4.8% | 4.9% | 3.9% | 5.3% | 4.7% | 5.2% | 7.3% | 7.2% |
| Stock comp / revenue | β | β | 0.3% | 0.3% | 0.4% | 0.4% | 0.3% | 0.4% | 0.4% | 0.4% |
| Payouts / FCF | β | β | 167.0% | 64.1% | 32.5% | 74.3% | 92.0% | 95.8% | 61.5% | 40.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | 7.0 | 8.0 | 6.0 | 6.0 | 6.0 | 7.0 |
| Altman Z'' | β | β | 2.4 | 2.5 | 3.1 | 3.8 | 4.2 | 4.0 | 3.5 | 3.6 |
| Accruals ratio | β | β | β | β4.6% | β6.1% | β3.0% | 0.1% | β4.0% | β3.1% | β3.4% |
Source: SEC EDGAR XBRL filings (CIK 0000849395). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.